GINER INC SBIR Phase I Award,
A SBIR Phase I contract was awarded to Giner, Inc. for $299,966.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
All edits
Edits on 3 Mar, 2024
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+456 characters)
GINER INC SBIR Phase I Award,
Article
Abstract
Point-of-Care HIV Viral Load, Drug Resistance, and Adherence Assays: The long-term goals of this program are to develop novel, low-cost, real-time point-of-care (POC) assays for 1. HIV Viral Load Monitoring; 2. HIV Drug Resistance Monitoring; and 3. Pharmacological Adherence Monitoring. This contract aims to develop an electrochemical POC test that will enable direct and label-free measurement of antiretroviral drugs in blood and urine samples.
Infobox
Is a
SBIR/STTR Award Recipient
Government Agency
0
Government Branch
Award Type
SBIR0
Contract Number (US Government)
75N93023C000200
Award Phase
Phase I0
Award Amount (USD)
299,9660
Official Website
Find more entities like GINER INC SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.